EDITORIALS
- The place of supervised injecting facilities within harm reduction: evidence, ethics and policy (pages 465–467) CRAIG L. FRY, STEFAN CVETKOVSKI and JACQUI CAMERON
- Do antagonists have a role in the treatment of opioid dependence? (pages 468–469) JEROME H. JAFFE
COMMENTARIES ON FERGUSSON ET AL. (2006)
- Testing the gateway hypothesis (pages 470–472) DENISE B. KANDEL, KAZUO YAMAGUCHI and LAURA COUSINO KLEIN
- Dissecting the causal anatomy of the link between cannabis and other illicit drugs (pages 472–473) WAYNE HALL
- Competing accounts of the gateway effect: the field thins, but still no clear winner (pages 473–474) ROBERT J. MACCOUN
- Testing the gateway hypothesis: Replies to HALL, KANDEL ET AL. AND MACCOUN (2006) (pages 474–476) DAVID M. FERGUSSON, JOSEPH M. BODEN and L. JOHN HORWOOD
NATIONAL EXPERIENCES
- Germany, alcohol and alcohol policy: oscillating between contemplation, action and relapse (pages 477–480) GERHARD BÜHRINGER
JOURNAL INTERVIEW 77
- Conversation with Joseph Gusfield (pages 481–490)
REVIEWS
- Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review (pages 491–503) Björn Axel Johansson, Mats Berglund and Anna Lindgren
METHODS AND TECHNIQUES
- A framework for reporting outcomes in problem gambling treatment research: the Banff, Alberta Consensus (pages 504–511) Michael Walker, Tony Toneatto, Marc N. Potenza, Nancy Petry, Robert Ladouceur, David C. Hodgins, Nady El-Guebaly, Enrique Echeburua and Alex Blaszczynski
RESEARCH REPORTS
- Childhood predictors of drunkenness in late adolescence among males: a 10-year population-based follow-up study (pages 512–521) Solja Niemelä, Andre Sourander, Kari Poikolainen, Hans Helenius, Lauri Sillanmäki, Kai Parkkola, Jorma Piha, Kirsti Kumpulainen, Fredrik Almqvist and Irma Moilanen
- Is alcopop consumption in Switzerland associated with riskier drinking patterns and more alcohol-related problems? (pages 522–533) Matthias Wicki, Gerhard Gmel, Emmanuel Kuntsche, Jürgen Rehm and Esther Grichting
- Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls (pages 534–547) Anna E. Goudriaan, Jaap Oosterlaan, Edwin De Beurs and Wim Van Den Brink
- Some characteristics of early-onset injection drug users prior to and at the time of their first injection (pages 548–555) Jeanne Abelson, Carla Treloar, June Crawford, Susan Kippax, Ingrid Van Beek and John Howard
- Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis (pages 556–569) David M. Fergusson, Joseph M. Boden and L. John Horwood
- Risk of harm among gamblers in the general population as a function of level of participation in gambling activities (pages 570–580) Shawn R. Currie, David C. Hodgins, JianLi Wang, Nady El-Guebaly, Harold Wynne and Sophie Chen
- Progression of oral snuff use among Finnish 13–16-year-old students and its relation to smoking behaviour (pages 581–589) Ari Haukkala, Erkki Vartiainen and Hein De Vries
- Evaluating the effectiveness of proactive telephone counselling for smoking cessation in a randomized controlled trial (pages 590–598) Hazel Gilbert and Stephen Sutton
- A smoking cessation intervention for the methadone-maintained (pages 599–607) Michael D. Stein, Marjorie C. Weinstock, Debra S. Herman, Bradley J. Anderson, Jennifer L. Anthony and Raymond Niaura
LETTERS TO THE EDITOR
- Buprenorphine in pregnancy: the advantages (page 608) JAMES J. NOCON
- Why not a statutory blood alcohol level for drinking in public places? (page 609) DAVID HAWKS
BOOK REVIEWS
- The taming of cocaine II (page 610) REGINALD SMART
- A biography of Mrs Marty Mann: the first lady of alcoholics anonymous (pages 610–611) BILL WHITE
- Clinical manual of addiction psychopharmacology (page 611) FALK KIEFER
- Drugs of abuse: body fluid testing (pages 611–612) DAVID COWAN